94750 Federal Register / Vol. 89, No. 230 / Friday, November 29, 2024 / Notices 

publishing additional ICPGs addressing 

other health care industry segments in 

the future. 

OIG welcomes written and specific 

feedback from the health care 

community and other stakeholders in 

connection with the GCPG and the 

Nursing Facility ICPG. Any such 

feedback can be submitted by email to 

Compliance@oig.hhs.gov. The receipt of 

any feedback does not obligate OIG to 

take action, including responding to the 

feedback, making the feedback public, 

or issuing or revising public guidance. 

III. Paperwork Reduction Act of 1995 

These resources contain no collection 

of information. Therefore, clearance by 

the Office of Management and Budget 

under the Paperwork Reduction Act of 

1995 is not required. 

Christi A. Grimm, 

Inspector General. 

[FR Doc. 2024–28019 Filed 11–27–24; 8:45 am] 

BILLING CODE 4152–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Interdisciplinary 

Molecular Sciences and Training 

Integrated Review Group, Center for 

Scientific Review Special Emphasis 

Panel, December 5, 2024, 10 a.m. to 

December 5, 2024, 4 p.m., National 

Institutes of Health, Rockledge II, 6701 

Rockledge Drive, Bethesda, MD 20892 

which was published in the Federal 

Register on November 08, 2024, 89 FR 

88789, Doc 2024–25937. 

This meeting is being amended to 

change the meeting start time from 

10:00 a.m. to 8:00 a.m. to accommodate 

an increase in applications being 

discussed. The meeting is closed to the 

public. 

Dated: November 22, 2024. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–28001 Filed 11–27–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; NIDDK High Risk 

Multi-Center Clinical Study Review Meeting. 

Date: January 22, 2025. 

Time: 10:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

NIDDK, Democracy II, Suite 7000A, 6707 

Democracy Boulevard, Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Michele L. Barnard, Ph.D., 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health, 

Room 7343, 6707 Democracy Boulevard, 

Bethesda, MD 20817, (301) 594–8898, 

barnardm@extra.niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: November 22, 2024. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–28002 Filed 11–27–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Proposed Collection; 60-Day Comment 

Request; Generic Clearance for the 

Collection of Qualitative Feedback on 

Agency Service Delivery (National 

Institute Allergy and Infectious 

Diseases) 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

requirement of the Paperwork 

Reduction Act of 1995 to provide 

opportunity for public comment on 

proposed data collection projects, the 

National Institute of Allergy and 

Infectious Diseases (NIAID) will publish 

periodic summaries of proposed 

projects to be submitted to the Office of 

Management and Budget (OMB) for 

review and approval. 

DATES: Comments regarding this 

information collection are best assured 

of having their full effect if received 

within 60 days of the date of this 

publication. 

FOR FURTHER INFORMATION CONTACT: To 

obtain a copy of the data collection 

plans and instruments, submit 

comments in writing, or request more 

information on the proposed project, 

contact: Sarah Hijaz, Health Science 

Policy Analyst, Office of Strategic 

Planning, Initiative Development and 

Analysis, 5601 Fishers Lane, Rockville, 

Maryland 20892 or call non-toll-free 

number (301)761–7790 or Email your 

request, including your address to: 

sarah.hijaz@nih.gov. Formal requests for 

additional plans and instruments must 

be requested in writing. 

SUPPLEMENTARY INFORMATION: Section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995 requires: written 

comments and/or suggestions from the 

public and affected agencies are invited 

to address one or more of the following 

points: (1) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

function of the agency, including 

whether the information will have 

practical utility; (2) The accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; (3) 

Ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (4) Ways to minimizes 

the burden of the collection of 

information on those who are to 

respond, including the use of 


khammond on DSK9W7S144PROD with NOTICES
Federal Register / Vol. 89, No. 230 / Friday, November 29, 2024 / Notices 94751 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

Proposed Collection Title: Generic 

Clearance for the Collection of 

Qualitative Feedback on Agency Service 

Delivery (NIAID), 0925–0668, 

Expiration Date 07/31/2025, 

EXTENSION, National Institute of 

Allergy and Infectious Diseases (NIAID). 

Need and Use of Information 

Collection: There are no changes being 

requested for this submission. The 

proposed information collection activity 

provides a means to garner qualitative 

customer and stakeholder feedback in 

an efficient, timely manner, in 

accordance with the Administration’s 

commitment to improving service 

delivery. By qualitative feedback we 

mean information that provides useful 

insights on perceptions and opinions 

but are not statistical surveys that yield 

quantitative results that can be 

generalized to the population of study. 

This feedback will provide information 

about the NIAID’s customer or 

stakeholder perceptions, experiences 

and expectations, provide an early 

warning of issues with service, or focus 

attention on areas where 

communication, training or changes in 

operations might improve delivery of 

products or services. These collections 

will allow for ongoing, collaborative and 

actionable communications between the 

NIAID and its customers and 

stakeholders. It will also allow feedback 

to contribute directly to the 

improvement of program management. 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours over 

3 years are 7200 (2400 per year). 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of collection Number of 

respondents 

Annual 

frequency per 

response 

Hours per 

response 

Total 

hours 

Customer satisfaction surveys ......................................................................... 4000 1 30/60 2000 

In-Depth Interviews (IDIs) or Small Discussion Groups .................................. 20 1 90/60 30 

Individual Brief Interviews ................................................................................ 40 1 15/60 10 

Focus Groups .................................................................................................. 30 1 2 60 

Pilot testing surveys ......................................................................................... 20 1 30/60 10 

Conferences and Training Pre- and Post-surveys .......................................... 500 1 30/60 250 

Website or Software Usability Tests ................................................................ 20 1 2 40 

Total .......................................................................................................... ........................ 4630 ........................ 2400 

Dated: November 22, 2024. 

Brandie K. Taylor Bumgardner, 

Project Clearance Liaison, National Institutes 

of Allergy and Infectious Diseases, National 

Institutes of Health. 

[FR Doc. 2024–27902 Filed 11–27–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Initial Review Group; Kidney, Urologic and 

Hematologic Diseases D Study Section 

Hoffert_2/25–27/2025. 

Date: February 25–27, 2025. 

Time: 5 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

NIDDK, Democracy II, Suite 7000A, 6707 

Democracy Boulevard, Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Jason D. Hoffert, Ph.D., 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health, 

Room 7343, 6707 Democracy Boulevard, 

Bethesda, MD 20817, 301–496–9010, 

hoffertj@niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS). 

Dated: November 22, 2024. 

Miguelina Pere,z 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–28000 Filed 11–27–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

BRAIN Initiative K99/R00 Application 

Review. 

Date: December 13, 2024. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. 

Meeting Format: Virtual Meeting. 


khammond on DSK9W7S144PROD with NOTICES